Trial Profile
A Phase II, Randomized, Placebo-Controlled, Study Assessing Efficacy and Safety of OC-10X Ophthalmic Suspension in the Treatment of Proliferative Diabetic Retinopathy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs OC 10X (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Sponsors OcuCure Therapeutics
- 03 Apr 2017 Status changed from recruiting to discontinued.
- 14 Apr 2016 New trial record